Biblioteca Humberto Rosselli Quijano
Resultado de la búsqueda
1 búsqueda de la palabra clave
'Antipsicóticos, Diseño de investigación, Esquizofrenia.' ![Resaltar las palabras buscadas Resaltar las palabras buscadas](./images/text_horizontalrule.png)
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
![+ info + info](./getgif.php?nomgif=plus)
[artículo] Título : |
Subject selection for the placebo- and comparator-controlled trials of neuroleptics in schizophrenia |
Tipo de documento: |
texto impreso |
Autores: |
Pavel Mohr, Autor ; Pál Czobor, Autor |
Fecha de publicación: |
2023 |
Artículo en la página: |
pp. 240-245 |
Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
Palabras clave: |
Antipsicóticos, Diseño de investigación, Esquizofrenia. |
Resumen: |
It has been suggested that inclusion of a placebo treatment arm in controlled clinical trials might bias the selection of study subjects. Presumably, patients in the placebo-controlled studies are more stable, but there are no data available to support such an assumption. The authors tested the hypothesis in a set of randomized trials of neuroleptics in treating schizophrenia by comparing placebo-controlled (PCTs) and comparator-controlled trials (CCTs) in terms of basic patient characteristics. |
Link: |
./index.php?lvl=notice_display&id=31221 |
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 2 (Abril) . - pp. 240-245
[artículo] Subject selection for the placebo- and comparator-controlled trials of neuroleptics in schizophrenia [texto impreso] / Pavel Mohr, Autor ; Pál Czobor, Autor . - 2023 . - pp. 240-245. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 2 (Abril) . - pp. 240-245 Palabras clave: |
Antipsicóticos, Diseño de investigación, Esquizofrenia. |
Resumen: |
It has been suggested that inclusion of a placebo treatment arm in controlled clinical trials might bias the selection of study subjects. Presumably, patients in the placebo-controlled studies are more stable, but there are no data available to support such an assumption. The authors tested the hypothesis in a set of randomized trials of neuroleptics in treating schizophrenia by comparing placebo-controlled (PCTs) and comparator-controlled trials (CCTs) in terms of basic patient characteristics. |
Link: |
./index.php?lvl=notice_display&id=31221 |
|